The 21st JBSA Annual Conference Program
December 5-7, 2022
Toyama Sunrise, Shinjyuku-ku, Tokyo

December 5, 2022 Preconference
Reception: 10:30～ Zoom access: 10:30～
Preconference [11:00〜17:00]
Moderator: Shigeo Iki (National Institute of Infectious Diseases)
Practical Risk Assessment for Exposure Response

December 6, 2022 Annual Conference (1st Day)
Reception: 9:00～
Zoom access: 9:30～
Opening remark [9：50～10：00]
Chairman: Kazutoshi Kogure (Hitachi Industrial Equipment Systems Co., Ltd.)
Katsuaki Shinohara (Shinshu University)
Educational lecture [10：00～12：00]
Chairman: Yasuhiro Kawai (National Institute of Infectious Diseases)
10:00~10:40
Risk Assessment in Biosafety - Risk Assessment Approach in the WHO Laboratory Biosafety
Manual, 4th Edition and Risk Assessment TrainingNational Institute of Infectious Diseases
Shigeo Iki
10:40~11:00
Risk assessment in Laboratory Biosafety guideline of Japanese Biological Science Association
Shinshu University
Katsuaki Shinohara
11:10~12:00
A study of biorisk management in microbiological laboratories
Nagasaki University
Yohei Kurosaki
Validation of steam sterilization procedures for decontamination
Nagasaki University
Misako Yajima
General meeting [13：10～13：40]
Chairman: Katsuaki Shinohara (Shinshu University)
Report from the committees [13：40～14：20]
Chairman: Atsuo Kitabayashi (The Corporation for Production and Research of Laboratory・IKARISHODOKU CO., LTD.)
Special lecture I [14：30～17：30]
Chairman: Katsuaki Shinohara (Shinshu University)
14:30~15:15
Summary of COVID-19 Infection Prevention and Control including Administrative
Responses
Tohoku Medical and Pharmaceutical University
Mitsuo Kaku
15:15~16:00
Evolution of SARS-CoV-2 and change of its pathogenesis
National Institute of Infectious Diseases
Ken Maeda

16:00~16:45
Development of COVID-19 Vaccine
National Institute of Infectious Diseases
16:45~17:30
Development of anti-COVID-19 drugs
National Institute of Infectious Diseases

Hideki Hasegawa

Koichi Watashi

Social gathering [18:00~ ]December 7, 2022 Annual Conference (2nd Day)
Reception: 8:30～
Zoom access: 9:00～
Special lecture II [9:15～11:30]
Chairman: Ken Maeda (National Institute of Infectious Diseases)
9:15～10:15
The Spread of The Novel Coronavirus Diseases (COVID-19)
National Defense Medical College
Koki Kaku, Atsuhiro Kanayama
10:15～11:00
COVID-19: Infection Prevention and Control in Health-care facilities.
St. Marianna University School of Medicine
Hiroyuki Kunishima
11:00～11:30
Personal Protective Equipment for COVID-19
Shinshu University
Katsuaki Shinohara
Company Presentation [11:30～12:30]
Chairman: Jyunichi Enokida (IKARI STERIFIRM CO., LTD)
1) NITTA AIR SOLUTIONS COMPANY
Kenichi Endo
2) Miltenyi Biotec K.K.
Akifumi Ogawa, Souhei Nakayama, Yoshihito Ootsuki
3) Hitachi Industrial Equipment Systems Co., Ltd.
Masashi Takasawa
4) IKARI STERIFIRM CO., LTD
Masahiro Shingaki, Toshio Sakai
Sympodium [13:30～15:30]
The Requirements, Responsibility and Role of Biosafety Specialists: Introduction of Biosafety
Specialist Education in JBSA
Chairman: Yohei Kurosaki (Nagasaki University)
13:30~14:00
Introduction the Laboratory Biosafety Specialist Certification System
The Corporation for Production and Research of Laboratory Primate･IKARI SHODOKUCO., LTD.
Atsuo Kitabayashi
14:00~14:30
Laboratory Biosafety Management - Introduction to WHO LBM (4th edition) and ISO35001 National Institute of Infectious Diseases
Kazuyoshi Sugiyama
14:30~15:00
Introduction to Architecture in Biosafety Facility Planning
Yamashita PMC Inc.,
Yasushi Sakata
15;00~15:30
Introduction of biosafety specialist education in JBSA:「Practice Introduction」
Hitachi Industrial Equipment Systems Co., Ltd.
Kazutoshi Kogure
IKARI STERIFIRM CO., LTD.
Akihiko SugiuraApplied Subjects [15:45～17:00]
Chairman: Kazutaka Ohsawa (Nagasaki University)
1) BSC fan should be run for some time before beginning work and after completion of workin the BSC.
Hitachi Industrial Equipment Systems Co., Ltd.
Keiichi Ono
2) New Biosafety Training Course at OIST
Okinawa Institute of Science and Technology Graduate University
Toshinori Tanaka
3) Inactivation of surfactants effective on SARS-CoV-2 against influenza viruses
National Institute of Infectious Diseases
Shigeo Iki, Hirotaka Takagi, Kenichi Hanaki
4）Chlorine dioxide gas decontamination of biological safety cabinet
1. IKARI STERIFIRM CO., LTD, 2. IKARI SHODOKU CO., LTD
Mingoo Park1, Megumi Tanaka2, Yuji Sasaki2, Toshio Sakai1, Akihiko Sugiura1
Closing remarks [17:00～]
Katsuaki Shinohara (Shinshu University)
Equipment exhibition [December 6 10:00～17:00, Dovember 7 10:00～16:00]
・AZEARTH Corporation
・IKARI STERIFIRM CO., LTD
・Hitachi Industrial Equipment Systems Co., Ltd.
・NITTA AIR SOLUTIONS COMPANY
・Miltenyi Biotec K.K.